Finance

Lists
OBAT:IDX
Brigit Biofarmaka Teknologi Tbk PT
IDR 218.00
+0.93%
(+2.00) 1D
Oct 2, 4:00:04 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for OBAT...
Open
IDR 216
High
IDR 220
Low
IDR 212
Mkt. cap
148.32B
Avg. vol.
633.99K
Volume
62.00K
Dividend
3.46%
Quarterly dividend
IDR 2
Ex-dividend date
May 22, 2026
P/E ratio
11.64
52-wk high
IDR 550
52-wk low
IDR 190
EPS
IDR 19
Shares outstanding
680.38M
No. of employees
17
Open
IDR 216
High
IDR 220
Low
IDR 212
Mkt. cap
148.32B
Avg. vol.
633.99K
Volume
62.00K
Dividend
3.46%
Quarterly dividend
IDR 2
Ex-dividend date
May 22, 2026
P/E ratio
11.64
52-wk high
IDR 550
52-wk low
IDR 190
EPS
IDR 19
Shares outstanding
680.38M
No. of employees
17
News stories
From web sources and news partners
About Brigit Biofarmaka Teknologi Tbk PT
CEO-
Employees17
Founded2015
Headquarters-
SectorPersonal care products
Websitebrigit.co.id
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
38.18B
45.37B
43.82B
45.18B
Cost of goods sold
18.76B
35.71B
28.17B
28.27B
Cost of revenue
18.76B
35.71B
28.17B
28.27B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.92B
6.42B
10.53B
10.81B
Operating expense
8.67B
7.08B
10.83B
10.70B
Total operating expenses
27.43B
42.80B
39.00B
38.97B
Operating income
10.75B
2.57B
4.83B
6.21B
Other non operating income
-54.54M
165.04M
242.73M
-92.66M
EBT including unusual items
10.67B
3.27B
4.87B
5.83B
EBT excluding unusual items
10.69B
3.25B
4.87B
5.83B
Income tax expense
4.46B
2.80B
-
1.39B
Effective tax rate
41.86%
85.71%
-
23.88%
Other operating expenses
751.69M
660.16M
296.55M
-105.38M
Net income
2.38B
2.47B
2.92B
4.40B
Net profit margin
6.22%
5.44%
6.65%
9.75%
Earnings per share
-
-
-
-
Interest and investment income
149.39M
1.36B
72.42M
13.58M
Interest expense
-156.33M
-1.34B
-266.58M
-301.05M
Net interest expenses
-6.94M
19.56M
-194.16M
-287.47M
Depreciation and amortization charges
-
-
-
-
EBITDA
11.71B
2.63B
5.73B
7.38B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps